The RCP prepared this briefing prior to the second reading in the House of Commons of the Access to Medical Treatments (Innovation) Bill.

The RCP's consultation response to the House of Commons Science and Technology Committee 2015 inquiry looking at the opportunities and risks of 'big data'.

This guideline offers evidence-based advice on the diagnosis and management of drug allergy in adults, children and young people. It does not cover treatment of the acute phase, including anaphylaxis